Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement Clinical Trial Optional)
ID: 344322Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344322

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PA-23-044.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced an opportunity for urgent competitive revisions to existing research grants and cooperative agreements, aimed at addressing unforeseen public health crises. This funding allows principal investigators to submit applications for modifications to their active grants to meet immediate needs that were not anticipated during the original grant application process. The opportunity is particularly significant as it underscores the NIH's commitment to adapting research efforts in response to critical public health situations, with eligibility extending to a wide range of organizations, including higher education institutions, nonprofits, and various government entities. Interested applicants should note that there are no specific budget limits, and applications must adhere to the new "FORMS-H" guidelines, with a submission deadline of October 25, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-23-044.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PA-23-044.html
    The National Institutes of Health (NIH) has released a funding opportunity announcement for urgent competitive revisions to existing research grants, specifically aimed at addressing unforeseen public health crises. This opportunity allows principal investigators to submit applications for modifications to their active grants to meet immediate needs not anticipated during the original grant application process. Eligible organizations include higher education institutions, nonprofits, and various government entities, among others. Applications must align with the missions of involved NIH institutes and follow strict guidelines, including the new "FORMS-H" application instructions. Funding is contingent on the NIH's appropriations, and there are no specific budget limits, as applicants should reflect the actual needs of their projects. Key dates, application procedures, and eligibility criteria are outlined clearly, emphasizing the importance of early application submission to correct any errors. Additionally, compliance with National Institutes of Health policies regarding human subject protections, inclusion of underrepresented groups, and substantial federal involvement is required. This funding opportunity underscores the NIH’s commitment to adapting research efforts in response to critical public health situations.
    Similar Opportunities
    Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced an Emergency Competitive Revision program aimed at providing funding for applications related to disasters declared under the Stafford Act or public health emergencies. This initiative is designed to support existing NIH awards and facilitate projects that address urgent public health issues stemming from such emergencies. Eligible applicants include a diverse range of organizations, such as higher education institutions, nonprofits, and local governments, particularly those impacted by recent disasters. The funding opportunity, designated as PA-24-201, opens on April 19, 2024, with applications due by April 18, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PA-24-201.html.
    Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for competing revisions to existing Single Project Research Grants and Cooperative Agreements, with the option for clinical trials. This initiative allows NIH award recipients to apply for additional funds to expand their current projects within the relevant Institutes and Centers, specifically in response to Notices of Special Interest (NOSI) issued by participating NIH entities. The funding opportunity, identified as PA-23-317, is open to a wide range of eligible applicants, including higher education institutions, nonprofit organizations, and foreign entities, reflecting NIH's commitment to advancing impactful health research. Applications must be submitted by November 24, 2026, through the NIH ASSIST system or Grants.gov, and will be evaluated based on scientific merit and adherence to specified criteria. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed)" aimed at facilitating urgent research on health outcomes related to unforeseen, time-sensitive events such as environmental threats, pandemics, or policy shifts. This grant program is designed to expedite the research process, allowing applications to be reviewed within eight weeks and funding awarded within four to five months from submission, with projects lasting up to five years. The initiative emphasizes collaboration with community entities and requires applicants to justify the time sensitivity of their research, outlining clear milestones for each phase of the project. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for March 2, 2025.
    Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Time-Sensitive Research Opportunities in Environmental Health Sciences" (NOFO RFA-ES-23-011) aimed at supporting urgent research in environmental health. This initiative focuses on addressing pressing environmental health issues arising from unpredictable events, such as natural disasters and policy changes, facilitating rapid data collection and analysis of human biological samples. With a total budget of $800,000 annually and individual awards capped at $275,000 over a maximum of two years, the program emphasizes an expedited review process, allowing for a complete cycle from submission to award within 4-6 months. Interested applicants can find more information and submit inquiries via email at grantsinfo@nih.gov, with applications due by December 1, 2025.
    Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Administrative Supplements to existing NIH grants and cooperative agreements to address unforeseen costs that arise within the scope of approved awards. This funding opportunity is designed for organizations holding eligible parent awards, allowing them to apply for additional support when costs increase or new research objectives emerge. The initiative underscores NIH's commitment to facilitating ongoing research by providing flexible funding options, although applicants should note that funding availability is not guaranteed and depends on appropriations and the merit of applications. Interested parties can find more information and submit inquiries to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV, with applications due by January 24, 2025.
    Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for revision applications from currently funded Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to enhance their support for outreach and research related to HIV and health disparities. The initiative aims to diversify and support the next generation of HIV/AIDS investigators by requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP), which will be a critical component of the application review process. This funding is vital for fostering innovative research and training programs that address key barriers in HIV research, particularly for underrepresented groups. The maximum award amount is $1.5 million annually, with applications due by October 9, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-080.html.
    Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities (R01- Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities" (FON: PAR-24-109), aimed at supporting collaborative research into the impacts of disasters on healthcare systems serving vulnerable populations in the U.S. and its territories. The initiative focuses on understanding the long-term effects, defined as one year or more post-disaster, on access, delivery, and quality of healthcare services, with an emphasis on fostering resilience and mitigating disparities exacerbated by such events. Eligible applicants include a wide range of institutions, including educational organizations, nonprofits, and government entities, with a funding ceiling of $500,000. The application period opens on May 5, 2024, and closes on June 5, 2024, with further inquiries directed to NIH Grants Information at grantsinfo@nih.gov.
    Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for organizations seeking to change the recipient organization of specific NIH grants. This initiative allows eligible applicants, including higher education institutions, nonprofits, and various government entities, to submit applications for the transfer of grant awards, ensuring continuity in research projects. While the submission of applications does not guarantee approval for the transfer, the NIH encourages coordination with relevant institutes and adherence to grant policies to facilitate a smooth transition. Interested parties can find more information and submit inquiries via email at grantsinfo@nih.gov, with key submission dates starting from July 12, 2024, and the opportunity closing on July 12, 2027.
    PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), in collaboration with the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), has announced the PHS 2024-2 Omnibus Solicitation for Small Business Innovation Research (SBIR) Grant Applications. This funding opportunity invites eligible U.S. small businesses to submit applications for Phase I, Phase II, Fast-Track, and Direct to Phase II projects that align with the research missions of the NIH, CDC, and FDA, with a focus on stimulating technological innovation and commercialization of federal R&D investments. Notably, applications must not include clinical trials, and funding levels are capped at $306,872 for Phase I and up to $2,045,816 for Phase II, with a submission deadline of April 5, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Mechanism for Time-Sensitive Substance Use Research" under the National Institute on Drug Abuse (NIDA). This grant, designated as R21, aims to support pilot, feasibility, and exploratory research addressing urgent issues in substance use epidemiology and health services, particularly in response to sudden increases in substance misuse and emerging public health challenges. Eligible applicants include a wide range of entities such as educational institutions, governmental bodies, and nonprofit organizations, with a budget cap of $275,000 over two years. Interested parties must submit their applications by September 9, 2027, and can direct inquiries to grantsinfo@nih.gov for further information.